In vitro activities of quinupristin-dalfopristin and the streptogramin RPR 106972 against Mycoplasma pneumoniae

Koichi Izumikawa, Yoichi Hirakata, Toshiyuki Yamaguchi, Ryoji Yoshida, Hironori Tanaka, Hiromu Takemura, Shigefumi Maesaki, Kazunori Tomono, Mitsuo Kaku, Kin Ichi Izumikawa, Shimeru Kamihira, Shigeru Kohno

研究成果: Article査読

8 被引用数 (Scopus)

抄録

The in vitro activities of quinupristin-dalfopristin and streptogramin RPR 106972 were determined with 44 strains of Mycoplasma pneumoniae and compared to those of macrolides, minocycline, and quinolones. All isolates tested were highly susceptible to macrolides and to quinupristin-dalfopristin (MIC at which 90% of the isolates are inhibited [MIC90], 0.0625 μg/ml), followed by RPR 106972 (MIC90, 0.5 μg/ml), quinolones, and minocycline.

本文言語English
ページ(範囲)698-699
ページ数2
ジャーナルAntimicrobial agents and chemotherapy
42
3
DOI
出版ステータスPublished - 1998 3
外部発表はい

ASJC Scopus subject areas

  • 薬理学
  • 薬理学(医学)
  • 感染症

フィンガープリント

「In vitro activities of quinupristin-dalfopristin and the streptogramin RPR 106972 against Mycoplasma pneumoniae」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル